Progesterone Capsule
Product Images NDC 69452-233

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 69452-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph1 (Figure001)

FDA Label Image

100 mg Capsules (Progesterone Image001)

This text has a warning message regarding the usage of a medication, which contains 100 mg ICronzed Pogesterone in the capsules. The warning states that the medication should not be used if the patient is allergic to peanuts. The medication is manufactured by a company named BI1ONPHARMA and is for prescription only. The text also provides the usual dose and the manufacturer's contact details.*

FDA Label Image

200 mg Capsules (Progesterone Image002)

BIONPHARMA produces capsules that contain 200 mg micronized progesterone. The recommended dosage can be found in the package insert that comes with the capsules. It is important to read the accompanying directions carefully and to store the capsules in a light-resistant container to protect from moisture. The capsules should be kept out of reach of children. Not recommended for those allergic to peanuts. This medicine is manufactured by Bionpharma Inc. in Princeton, NJ.*

FDA Label Image

Chemical Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.